The FDA – Lenexa laboratory is a relocation of the former Kansas City District Laboratory and features a number of upgraded capabilities in order for the FDA to effectively conduct its mission. With a significant increase in size over its former location, the new state-of-the-art laboratory offers services through the following laboratory sections: the Total Diet and Pesticides Research Center (TDPRC), Pesticides analysis, Chemotherapeutics / LC-MS Poison screening, Mycotoxins analysis, Drugs and Dietary Supplements analysis, Dioxins analysis, Metals / Elemental Specialization analysis, and Laboratory Administration.
FDA – Lenexa is one of 13 regional laboratories strategically located throughout the country. The approximately $67 million project achieved substantial completion in the third quarter of 2020 and a 20-year lease term then commenced with the General Services Administration (GSA) for the beneficial use of the FDA.
FDA – Lenexa is the second FDA re-development project in the Easterly portfolio, following the 2019 delivery of FDA – Alameda and preceding the anticipated future delivery of FDA – Atlanta.